West Enclave Merger Corp. quarterly report, Q3 FY2026

West Enclave Merger Corp. — Form 10-Q Summary

Reporting period: Quarter ended September 30, 2026. Filed November 16, 2026. West Enclave is a Cayman Islands blank-check company formed to pursue a business combination; it had not begun operating activities or identified a completed transaction in the filing. Its securities trade on the NYSE as WENC U, WENC and WENC RT.

Financial results and position

  • Revenue and earnings: No operating revenue. For the quarter, net income was $931,674, comprising $1,066,618 of trust-account interest less $134,944 of general and administrative costs. For the nine months, net income was $1,401,131, including $1,718,069 of interest and $316,938 of general and administrative costs. Operating losses were $134,944 and $316,938, respectively. Basic and diluted earnings per share were $0.06 for the quarter and $0.13 for the nine months.
  • Comparability: The company was incorporated in December 2025 and reports no comparative statement-of-operations period. The balance sheet compares September 30, 2026 with December 31, 2025.
  • Cash flow: Nine-month operating cash use was $318,216; investing cash use was $116.15 million, primarily the trust-account deposit; financing cash provided was $117.27 million. Ending cash outside the trust was $798,440.
  • Assets and liquidity: Total assets were $118.79 million, including $117.87 million in the trust account, invested substantially in a U.S. Treasury money market fund. Working capital was $705,428. Redeemable shares of $117.87 million are classified as temporary equity.
  • Debt and obligations: Total liabilities were $482,782, including a $287,500 EBC loan, $195,282 of current liabilities and no outstanding working-capital loans. The EBC loan is not repayable from trust funds if the company fails to complete a business combination. The company reports no long-term debt, lease obligations or off-balance-sheet arrangements.
  • Margins: Operating margins are not meaningful because the company has no operating revenue; reported profit is driven by trust interest.

Material developments and outlook

  • The company completed its IPO in May 2026, selling 11.5 million public units for $115 million, and sold 466,250 private-placement units for $4.66 million. It deposited $116.15 million into the trust. The underwriters fully exercised the over-allotment option.
  • Trust interest and related accretion increased the redemption value of public shares; the filing reports $7.67 million of noncash accretion for the nine months.
  • Public shareholders may redeem shares in connection with a business combination. The company has 21 months from the IPO closing to complete one, unless shareholders extend the period; otherwise, public shares are to be redeemed and the company liquidated, subject to applicable obligations.
  • Management says existing funds should cover working-capital needs for at least one year, but warns that higher-than-estimated target-search, due-diligence or transaction costs could leave insufficient funds before a business combination. Management may seek, but is not assured of, working-capital loans.
  • Upon completion of a business combination, EBC is entitled to a marketing fee equal to 3.5% of IPO gross proceeds, with a minimum fee of $2 million. The company also pays the Sponsor or an affiliate $10,000 monthly for administrative services.
  • No specific business-combination guidance or target outlook is provided. The filing states there is no assurance the company will complete a transaction. No material risk-factor changes, legal proceedings or subsequent events requiring disclosure were reported. Management reported effective disclosure controls and no material change in internal control over financial reporting.

Important facts for investors to verify

  • Whether a target has been identified or a transaction agreement announced since the reporting date, and the timetable for completing a business combination.
  • The redemption and extension terms, including the amount ultimately available per public share and the effect of any redemptions on transaction funding.
  • Whether cash outside the trust is sufficient for ongoing search and transaction costs, and whether additional sponsor or related-party financing is needed.
  • The terms and repayment treatment of the $287,500 EBC loan and the contingent EBC marketing fee.
  • That reported earnings reflect trust-account interest, not operating revenue, and that prior-period operating comparisons are unavailable.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.